Profile data is unavailable for this security.
About the company
Monash IVF Group Limited is a provider of Assisted Reproductive Services (ARS). It offers a range of techniques used to assist patients experiencing infertility in achieving a clinical pregnancy, including reproductive genetic services. It is also a provider of specialized women's imaging services. It provides a range of specialist diagnostic obstetric and gynecological ultrasound and fertility treatment. Its segments consist of two operations: Australia IVF and Ultrasound, providing ARS, ultrasound and other related services. International IVF, providing ARS in Southeast Asia. Its business includes fertility solutions that provide fertility treatment and care; KL Fertility is a fertility specialist center; Monash IVF is a fertility research and treatment center; Monash IVF KPJ Johor is a full-service hospital-based fertility center, and Monash Ultrasound for Women provides tertiary level prenatal diagnostic services. Its business also includes Repromed and Sydney Ultrasound for Women.
- Revenue in AUD (TTM)269.47m
- Net income in AUD15.16m
- Incorporated2014
- Employees892.00
- LocationMonash IVF Group LtdLevel 1, 510 Church St, CremorneRICHMOND 3121AustraliaAUS
- Phone+61 39420-8235
- Websitehttps://www.monashivfgroup.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cryosite Ltd | 14.12m | 1.88m | 58.82m | 25.00 | 33.10 | 25.54 | 22.15 | 4.32 | 0.0378 | 0.0378 | 0.2834 | 0.049 | 0.7206 | 102.47 | 7.87 | 564,640.00 | 9.62 | 6.66 | 12.29 | 8.09 | 62.98 | 60.87 | 13.35 | 11.83 | 1.95 | -- | 0.4869 | -- | 11.93 | 9.38 | 2.39 | 4.94 | -8.42 | -- |
| Cleo Diagnostics Ltd | 2.80m | -4.03m | 80.06m | -- | -- | 8.68 | -- | 27.37 | -0.0298 | -0.0298 | 0.0207 | 0.0645 | 0.3138 | -- | 31.00 | -- | -45.18 | -- | -49.57 | -- | -- | -- | -143.99 | -- | -- | -- | 0.00 | -- | 97.41 | -- | -6.38 | -- | -- | -- |
| Eureka Group Holdings Ltd | 45.79m | 20.06m | 221.82m | 42.00 | 10.47 | 0.9357 | 11.00 | 4.94 | 0.0506 | 0.0506 | 0.1189 | 0.5664 | 0.1506 | -- | 206.26 | -- | 6.60 | 6.12 | 6.75 | 6.29 | 54.76 | 52.75 | 43.81 | 37.02 | -- | -- | 0.1908 | 30.22 | 11.30 | 13.04 | 51.90 | 19.90 | 21.25 | 6.71 |
| Monash IVF Group Ltd | 269.47m | 15.16m | 270.80m | 892.00 | 17.78 | 1.05 | 6.83 | 0.9905 | 0.0385 | 0.0385 | 0.6845 | 0.6517 | 0.5295 | 3.09 | 8.38 | 302,099.80 | 3.13 | 4.12 | 3.68 | 4.84 | 89.02 | 89.42 | 5.91 | 7.69 | 0.624 | 4.44 | 0.4339 | 85.77 | 6.65 | 13.34 | 483.15 | 16.36 | 13.96 | 5.80 |
| Australian Clinical Labs Ltd | 737.49m | 26.31m | 434.42m | 4.70k | 15.41 | 2.83 | 2.64 | 0.5785 | 0.1447 | 0.1447 | 3.95 | 0.7874 | 1.29 | 7.62 | 12.12 | 156,913.00 | 4.65 | 12.05 | 7.20 | 18.53 | 82.92 | 81.44 | 3.62 | 8.79 | 0.5022 | 4.40 | 0.676 | 55.61 | 6.45 | 8.61 | 35.50 | -4.70 | -2.16 | -- |
| Healius Ltd | 1.37bn | -549.20m | 497.40m | 8.00k | -- | 0.8733 | -- | 0.3551 | -0.7564 | -0.2325 | 1.89 | 0.7672 | 0.5661 | 6.27 | 8.81 | 171,250.00 | -22.69 | -7.07 | -30.57 | -8.67 | 84.50 | 85.70 | -40.09 | -14.73 | 0.4999 | 0.3194 | 0.6279 | -- | 5.69 | -2.90 | 15.97 | -- | -7.13 | -- |
| Artrya Ltd | 28.00k | -16.41m | 537.49m | -- | -- | 16.45 | -- | 17,445.70 | -0.1782 | -0.1782 | 0.0003 | 0.1878 | 0.0013 | -- | 0.006 | -- | -76.86 | -50.54 | -84.04 | -53.79 | -- | -- | -58,592.86 | -224,202.80 | -- | -- | 0.0285 | -- | -- | -- | -17.19 | -- | 76.21 | -- |
| Australian Unity Ltd | 2.56bn | 29.28m | 584.72m | 7.70k | -- | -- | 5.68 | 0.2268 | -- | -- | -- | -- | 0.2504 | -- | -- | -- | 0.2863 | 0.2535 | -- | -- | -- | -- | 1.14 | 1.08 | -- | 2.32 | 0.3517 | -- | 19.22 | 12.82 | 225.85 | 26.26 | -3.12 | -- |
| Integral Diagnostics Ltd | 768.44m | 14.03m | 909.94m | 3.03k | 64.28 | 1.32 | 10.69 | 1.17 | 0.0375 | 0.0375 | 2.06 | 1.82 | 0.5524 | 12.33 | 25.44 | 254,028.80 | 1.02 | 0.3746 | 1.13 | 0.4202 | 95.56 | 95.19 | 1.85 | 0.668 | 0.6047 | 2.17 | 0.4687 | 568.89 | 33.70 | 17.91 | 107.70 | -27.31 | 18.22 | -7.07 |
| Holder | Shares | % Held |
|---|---|---|
| Argo Investments Ltd. (Investment Management)as of 30 Sep 2025 | 24.38m | 6.26% |
| Tribeca Investment Partners Pty Ltd.as of 01 Feb 2025 | 24.10m | 6.19% |
| Lennox Capital Partners Pty Ltd.as of 10 Jun 2025 | 19.69m | 5.05% |
| Challenger Ltd. (Investment Management)as of 10 Jun 2025 | 19.69m | 5.05% |
| UniSuper Management Pty Ltd.as of 11 Apr 2025 | 17.10m | 4.39% |
| Regal Funds Management Pty Ltd.as of 21 Nov 2025 | 7.20m | 1.85% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 6.19m | 1.59% |
| DFA Australia Ltd.as of 31 Jan 2026 | 4.76m | 1.22% |
| Netwealth Investments Ltd.as of 30 Sep 2025 | 1.71m | 0.44% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 690.39k | 0.18% |
